Ugur Sahin – Chief Executive Officer
E812196
Ugur Sahin is a German immunologist, oncologist, and entrepreneur best known as the co-founder and CEO of BioNTech, where he led development of one of the first mRNA-based COVID-19 vaccines.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Ugur Sahin – Chief Executive Officer canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T9632090 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: Ugur Sahin – Chief Executive Officer Context triple: [BioNTech, positionHeld, Ugur Sahin – Chief Executive Officer]
-
A.
David L. Gitlin – Chief Executive Officer
David L. Gitlin is an American business executive who serves as the chief executive officer of Carrier Global Corporation, a leading provider of heating, ventilation, air conditioning, and refrigeration solutions.
-
B.
Marcelo Claure – CEO
Marcelo Claure is a Bolivian-American businessman best known for leading Sprint Corporation as its CEO and for his prominent roles within SoftBank’s global telecommunications and investment ventures.
-
C.
Arnaud de Puyfontaine – CEO
Arnaud de Puyfontaine is a French media executive known for leading the multinational entertainment and communications group Vivendi as its chief executive officer.
-
D.
Patrick Soon-Shiong
Patrick Soon-Shiong is a South African-born American surgeon, biotech entrepreneur, and billionaire known for developing the cancer drug Abraxane and owning major media and healthcare enterprises.
-
E.
Jamie Salter – Chief Executive Officer
Jamie Salter – Chief Executive Officer is a Canadian entrepreneur and business executive best known as the founder and longtime leader of brand management company Authentic Brands Group.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: Ugur Sahin – Chief Executive Officer Target entity description: Ugur Sahin is a German immunologist, oncologist, and entrepreneur best known as the co-founder and CEO of BioNTech, where he led development of one of the first mRNA-based COVID-19 vaccines.
-
A.
David L. Gitlin – Chief Executive Officer
David L. Gitlin is an American business executive who serves as the chief executive officer of Carrier Global Corporation, a leading provider of heating, ventilation, air conditioning, and refrigeration solutions.
-
B.
Marcelo Claure – CEO
Marcelo Claure is a Bolivian-American businessman best known for leading Sprint Corporation as its CEO and for his prominent roles within SoftBank’s global telecommunications and investment ventures.
-
C.
Arnaud de Puyfontaine – CEO
Arnaud de Puyfontaine is a French media executive known for leading the multinational entertainment and communications group Vivendi as its chief executive officer.
-
D.
Patrick Soon-Shiong
Patrick Soon-Shiong is a South African-born American surgeon, biotech entrepreneur, and billionaire known for developing the cancer drug Abraxane and owning major media and healthcare enterprises.
-
E.
Jamie Salter – Chief Executive Officer
Jamie Salter – Chief Executive Officer is a Canadian entrepreneur and business executive best known as the founder and longtime leader of brand management company Authentic Brands Group.
- F. None of above. chosen
Statements (46)
| Predicate | Object |
|---|---|
| instanceOf |
entrepreneur
ⓘ
human ⓘ immunologist ⓘ |
| academicDegree | Doctor of Medicine ⓘ |
| awardReceived |
Axel Springer Award
NERFINISHED
ⓘ
Order of Merit of the Federal Republic of Germany NERFINISHED ⓘ Paul Ehrlich and Ludwig Darmstaedter Prize NERFINISHED ⓘ |
| citizenship |
Germany
ⓘ
Turkey NERFINISHED ⓘ |
| coFounded | BioNTech NERFINISHED ⓘ |
| collaboratedWith | Pfizer NERFINISHED ⓘ |
| countryOfBirth | Turkey NERFINISHED ⓘ |
| dateOfBirth | 1965-09-19 ⓘ |
| educatedAt |
University of Cologne
NERFINISHED
ⓘ
University of Saarland NERFINISHED ⓘ |
| employer | BioNTech NERFINISHED ⓘ |
| ethnicOrigin | Turkish ⓘ |
| familyName | Sahin NERFINISHED ⓘ |
| fieldOfWork |
cancer immunotherapy
ⓘ
immunology ⓘ mRNA technology ⓘ oncology ⓘ |
| gender | male ⓘ |
| givenName | Ugur NERFINISHED ⓘ |
| knownFor |
co-founding BioNTech
ⓘ
developing mRNA-based COVID-19 vaccine ⓘ research in cancer immunotherapy ⓘ |
| memberOf | German National Academy of Sciences Leopoldina NERFINISHED ⓘ |
| name | Ugur Sahin NERFINISHED ⓘ |
| notableAchievement | led development of one of the first authorized mRNA COVID-19 vaccines at BioNTech ⓘ |
| notableRole | Chief Executive Officer of BioNTech NERFINISHED ⓘ |
| notableWork | development of BNT162b2 COVID-19 vaccine ⓘ |
| occupation |
businessperson
ⓘ
chief executive officer ⓘ immunologist ⓘ oncologist ⓘ university teacher ⓘ |
| placeOfBirth | Iskenderun NERFINISHED ⓘ |
| positionHeld |
Chief Executive Officer of BioNTech
ⓘ
co-founder of BioNTech ⓘ |
| researchInterest |
T-cell immunology
ⓘ
personalized cancer vaccines ⓘ |
| residence | Mainz NERFINISHED ⓘ |
| spouse | Ozlem Tureci NERFINISHED ⓘ |
| workLocation |
Germany
ⓘ
Mainz NERFINISHED ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: Ugur Sahin – Chief Executive Officer Description of subject: Ugur Sahin is a German immunologist, oncologist, and entrepreneur best known as the co-founder and CEO of BioNTech, where he led development of one of the first mRNA-based COVID-19 vaccines.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.